北美疟疾治疗市场预测至 2030 年 - 区域分析 - 按治疗(仿制药、原创药、疫苗等)、给药途径(口服和肠外给药)和分销渠道(直接招标、医院药房、零售药房、网上药房等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 84    |    Report Code: TIPRE00025040    |    Category: Life Sciences

North America Malaria Treatment Market
2022 年北美疟疾治疗市场价值为 6297 万美元,预计到 2030 年将达到 4.8731 亿美元;预计 2022 年至 2030 年的复合年增长率为 29.1%。

疟疾患病率不断上升推动北美疟疾治疗市场发展

疟疾是一种急性发热性疾病,由疟原虫引起,通过受感染的雌性按蚊传播。人类五种寄生虫主要导致疟疾,其中两种——恶性疟原虫和间日疟原虫——被认为是对人类健康的最大威胁。此外,恶性疟原虫是最致命的疟疾寄生虫,在非洲大陆传播最为广泛。此外,间日疟原虫是撒哈拉以南非洲以外大多数国家的主要疟疾寄生虫。根据世界卫生组织 (WHO) 最新的《2020 年世界疟疾报告》(WMR),全球报告了 2.41 亿例疟疾病例,而 2019 年记录的病例为 2.27 亿例。根据同一来源,疟疾造成的死亡人数每年增加 69,000 人。其中约三分之二(即 47,000 人)的死亡是由于 COVID-19 爆发期间医疗服务中断造成的;其余三分之一的死亡,即 22,000 人,反映了世卫组织最近计算疟疾死亡率的方法的变化(不考虑 COVID-19 中断)。因此,疟疾患病率的上升推动了疟疾治疗市场的增长。

北美疟疾治疗市场概览

据美国疾病控制与预防中心 (CDC) 称,美国每年报告约 2,000 例疟疾病例,其中大部分是来自其他国家的旅行者和移民。孕妇和 5 岁以下儿童感染疟疾和发展为严重疾病的风险最高。由于能够在美国传播疟疾的按蚊(媒介)的持久性,美国存在疟疾传播可能恢复的永久风险。根据全球基金 2022 年 4 月的数据,与疟疾有关的病例和死亡人数增加主要是由于 COVID-19 大流行造成的资金停滞和中断。然而,正如全球基金 2022 年 9 月报告中提到的那样,缓解这些影响的努力已经取得进展。美国政府为控制疟疾而采取的努力包括主要通过美国总统疟疾倡议 (PMI) 开展的活动,该倡议由美国全球疟疾协调员监督。根据全球卫生政策,美国在 2022 财年用于疟疾控制和研究活动的资金约为 10 亿美元。美国政府在 PMI 战略 2021-2026 下的目标是努力减少疟疾造成的死亡并降低疟疾发病率,从而接近其消除疟疾的长期目标。

因此,美国疟疾治疗市场的增长是由疟疾患者数量的增加推动的。

北美疟疾治疗市场收入和预测到 2030 年(百万美元)

北美疟疾治疗市场细分

北美疟疾治疗市场根据治疗、给药途径、分销渠道和国家进行细分。根据治疗方法,北美疟疾治疗市场细分为仿制药、原研药、疫苗和其他。疫苗部分在 2022 年占据了最大的市场份额。

就给药途径而言,北美疟疾治疗市场分为口服和肠外给药。 2022 年,口服药物占据了更大的市场份额。

按分销渠道,北美疟疾治疗市场细分为直接招标、医院药房、零售药房、在线药房等。直接招标部分在 2022 年占据了最大的市场份额。

根据国家/地区,北美疟疾治疗市场细分为美国、加拿大和墨西哥。2022 年,美国占据了北美疟疾治疗市场份额的主导地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、Sanofi SA、GSK Plc、Novartis AG、Pfizer Inc、AdvaCare Pharma USA LLC、VLP Therapeutics LLC 和 Lupin Ltd 是北美疟疾治疗市场的一些领先参与者。

North America Malaria Treatment Strategic Insights

Strategic insights for North America Malaria Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-malaria-treatment-market-strategic-framework.webp
Get more information on this report

North America Malaria Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 62.97 Million
Market Size by 2030 US$ 487.31 Million
Global CAGR (2022 - 2030) 29.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 治疗
  • 仿制药
  • 原创药物
  • 疫苗
By 给药途径
  • 口服
  • 肠胃外
By 分销渠道
  • 直接招标
  • 医院药房
  • 零售药房
  • 网上药房
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd
  • Get more information on this report

    North America Malaria Treatment Regional Insights

    The regional scope of North America Malaria Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-malaria-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - North America Malaria Treatment Market

    1. Cipla Ltd
    2. Sun Pharmaceutical Industries Ltd
    3. Sanofi SA
    4. GSK Plc
    5. Novartis AG
    6. Pfizer Inc
    7. AdvaCare Pharma USA LLC
    8. VLP Therapeutics LLC
    9. Lupin Ltd

    Frequently Asked Questions
    How big is the North America Malaria Treatment Market?

    The North America Malaria Treatment Market is valued at US$ 62.97 Million in 2022, it is projected to reach US$ 487.31 Million by 2030.

    What is the CAGR for North America Malaria Treatment Market by (2022 - 2030)?

    As per our report North America Malaria Treatment Market, the market size is valued at US$ 62.97 Million in 2022, projecting it to reach US$ 487.31 Million by 2030. This translates to a CAGR of approximately 29.1% during the forecast period.

    What segments are covered in this report?

    The North America Malaria Treatment Market report typically cover these key segments-

  • 治疗 (仿制药, 原创药物, 疫苗)
  • 给药途径 (口服, 肠胃外)
  • 分销渠道 (直接招标, 医院药房, 零售药房, 网上药房)
  • What is the historic period, base year, and forecast period taken for North America Malaria Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Malaria Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in North America Malaria Treatment Market?

    The North America Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd
  • Who should buy this report?

    The North America Malaria Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.